VENKATA NARAYANA ACTIVE INGREDIENTS

Company Introduction for VENKATA NARAYANA ACTIVE INGREDIENTS PTE. LTD., Singapore:

VENKATA NARAYANA ACTIVE INGREDIENTS PTE. LTD. is a Singapore-based company primarily engaged in the sourcing, supply, and distribution of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, excipients, and specialty chemicals. The company serves various industries, including pharmaceutical, nutraceutical, and chemical sectors, by providing a comprehensive range of raw materials. They focus on establishing robust supply chains and offering high-quality products sourced from various global manufacturers to meet the specific requirements of their clients. Their operations involve global procurement, logistics, and distribution services, ensuring timely and efficient delivery of critical ingredients.

Type of Company: Trader/Distributor

Rationale: Based on publicly available business information and common classifications, VENKATA NARAYANA ACTIVE INGREDIENTS PTE. LTD. primarily functions as a wholesale distributor and trader of chemical and pharmaceutical products. While some business registrations may include general manufacturing of chemical products, their core business activities are consistently listed as wholesale and supply chain management, indicating their primary role as a supplier and distributor rather than a large-scale manufacturer of Active Pharmaceutical Ingredients.

Venkata Narayana Active Ingredients Pte Ltd in Singapore primarily sells and distributes a range of Active Pharmaceutical Ingredients (APIs) and advanced intermediates. These products are generally manufactured by its associated company, Venkata Narayana Active Ingredients Private Limited, based in India.

The product portfolio includes, but is not limited to, the following APIs:

Fexofenadine Hydrochloride

Rosuvastatin Calcium

Atorvastatin Calcium

Montelukast Sodium

Sitagliptin Phosphate

Vildagliptin

Empagliflozin

Rivaroxaban

Apixaban

Ticagrelor

Apremilast

Tofacitinib Citrate

Ibrutinib

Osimertinib

Lenalidomide